Mirae Asset Global ETFs Holdings
RVMD icon

Mirae Asset Global ETFs Holdings’s Revolution Medicines RVMD Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.27M Sell
29,309
-11,319
-28% -$1.65M 0.01% 841
2026
Q1 		$3.81M Buy
40,628
+36,252
+828% +$3.66M 0.01% 907
2025
Q4 		$349K Sell
4,376
-4,820
-52% -$316K ﹤0.01% 2077
2025
Q3 		$424K Buy
9,196
+1,724
+23% +$67.5K ﹤0.01% 1944
2025
Q2 		$276K Sell
7,472
-101,532
-93% -$3.9M ﹤0.01% 2113
2025
Q1 		$3.87M Buy
109,004
+6,877
+7% +$279K 0.01% 841
2024
Q4 		$4.46M Buy
102,127
+12,084
+13% +$610K 0.01% 804
2024
Q3 		$4.08M Buy
90,043
+13,093
+17% +$570K 0.01% 832
2024
Q2 		$2.98M Buy
+76,950
New +$2.88M 0.01% 925

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's RVMD Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings reduced its Revolution Medicines (RVMD) stake by 28% in Q2 2026, selling an estimated $1.65M and leaving 29,309 shares worth $5.27M. The position accounts for 0.01% of the portfolio, ranked #841.

Mirae Asset Global ETFs Holdings first reported a position in RVMD in Q2 2024 and has held it in 9 quarters since. 694 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 29,309 shares of Revolution Medicines worth $5.27M as of Q2 2026.
  • Mirae Asset Global ETFs Holdings sold 11,319 Revolution Medicines shares in Q2 2026, an estimated $1.65M.
  • Revolution Medicines made up 0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #841 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Revolution Medicines in Q2 2024 and has held it in 9 quarters since.
  • 694 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.